[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2024 POC Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts-Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

July 2020 | 418 pages | ID: 2AC1966D37F1EN
Venture Planning Group

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 418-page report from LeadingMarketResearch contains 42 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. The report is available by section, and can be customized to specific information needs and budget. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis
  • Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:
    • Physician Offices/Group Practices
    • Emergency Rooms
    • Operating/Recovery Suites
    • ICUs/CCUs
    • Cancer Clinics
    • Ambulatory Care Centers
    • Surgery Centers
    • Nursing Homes
    • Birth Centers
Sales and Market Share Analysis

Sales and market shares of major coagulation reagent and instrument suppliers.

Current and Emerging Products
  • Analysis of coagulation procedures performed in POC testing locations.
  • Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive Assessments

Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations
  • Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.
Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 418 pages and 42 tables
INTRODUCTION

EXECUTIVE SUMMARY

Rationale for Testing Decentralization
  1. Overview
  2. Regulatory Trends
  3. Economic Trends
  4. Demographic Trends
  5. Technological Trends
  6. Social Trends
  7. Quality of Care
  8. Defensive Medicine
  9. Quality Control Issues
Worldwide Market and Technology Overview
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Factor VIII
  8. Fibrin Degradation Products
  9. Fibrinogen
  10. Heparin
  11. Proteins C and S
  12. Prothrombin Time (PT)
  13. Thrombin Time
Instrumentation: Coagulation Analyzers Manufactured by:
      Behnk Elektronik
      Bio/Data
      Diagnostica Stago
      Helena Laboratories
      Instrumentation Laboratory
      Roche
      Siemens Healthineers
      Sysmex
      Teco
Current and Emerging Technologies
U.S.A.
  1. Monoclonal Antibodies
  2. Immunoassays
  3. Dry Chemistry
  4. Biosensors
  5. IT and Automation
  6. Molecular Diagnostics
A. Market Overview
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
      PPO
      HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
      More Chronic Illness
      Disease Incidence
      Susceptibility to latrogenesis
      Multiple Illnesses Cases
    l. Laboratory Regulations
  2. Market Structure
    a. Hospitals
    b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
  1. Market Summary
  2. Market Structure
  3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
  1. Introduction
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. Emergency Departments
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. Operating and Recovery Suites
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUs/CCUs
    a. Market Summary
    b. Test Volume and Sales Forecasts
D. Cancer Clinics
  1. Introduction
  2. Market Summary
  3. Test Volume and Sales Forecasts
E. Ambulatory Care Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
F. Surgery Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
G. Nursing Homes
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
H. Birth Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
I. Major Suppliers Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPANY PROFILE

The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others

LIST OF TABLES

Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin Ill Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-Dimer Tests
Major Companies Developing or Marketing Factor Assays Tests
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Coagulation Test Volume Forecast
U.S.A., Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
U.S.A., Cancer Clinics Major Coagulation Test Volume Forecast
U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Coagulation Test Volume Forecast
U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Coagulation Test Volume Forecast
U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Coagulation Test Volume Forecast
U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares


More Publications